Karachi: Citi Pharma Limited announced a leadership change within its financial department, appointing Mr. Muhammad Naveed Uddin as the new Chief Financial Officer, effective immediately. This development follows a previous interim arrangement where Mr. Hanan Alam, the Financial Controller, took on the acting CFO role.

According to the company’s report dated October 26, 2026, the decision was approved by the Board of Directors. Mr. Naveed Uddin steps into the CFO position, bringing a new phase of leadership to the financial operations of Citi Pharma Limited. Mr. Hanan Alam will continue his role as the Financial Controller, ensuring continuity within the department.

Citi Pharma Limited operates within the pharmaceutical sector, a designated market category that is crucial to health and medicine industries. The company's strategic decisions, such as the appointment of Mr. Naveed Uddin, reflect ongoing efforts to strengthen its leadership team.

According to information available from the Pakistan Stock Exchange (PSX), such leadership appointments are pivotal to maintaining investor confidence and ensuring the continued financial health of companies within the pharmaceutical sector.

The company had previously assigned Mr. Alam the acting CFO responsibilities on August 07, 2026, indicating a period of transition within its financial management framework. The recent appointment of Mr. Naveed Uddin marks a significant step in establishing a permanent leadership structure for its financial operations.